Cargando…
Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649393/ http://dx.doi.org/10.1186/2051-1426-3-S2-P372 |
| _version_ | 1782401348784881664 |
|---|---|
| author | Skarzynski, Martin Lindorfer, Margeret Butera, Vicent Vire, Berengere Farooqui, Mohammed Rader, Christoph Taylor, Ronald Wiestner, Adrian |
| author_facet | Skarzynski, Martin Lindorfer, Margeret Butera, Vicent Vire, Berengere Farooqui, Mohammed Rader, Christoph Taylor, Ronald Wiestner, Adrian |
| author_sort | Skarzynski, Martin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649393 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493932015-11-24 Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants Skarzynski, Martin Lindorfer, Margeret Butera, Vicent Vire, Berengere Farooqui, Mohammed Rader, Christoph Taylor, Ronald Wiestner, Adrian J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649393/ http://dx.doi.org/10.1186/2051-1426-3-S2-P372 Text en Copyright © 2015 Skarzynski et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Skarzynski, Martin Lindorfer, Margeret Butera, Vicent Vire, Berengere Farooqui, Mohammed Rader, Christoph Taylor, Ronald Wiestner, Adrian Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants |
| title | Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants |
| title_full | Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants |
| title_fullStr | Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants |
| title_full_unstemmed | Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants |
| title_short | Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants |
| title_sort | monoclonal antibodies targeting cell surface deposited complement fragment c3d potentiate cancer immunotherapy and eliminate antigen loss variants |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649393/ http://dx.doi.org/10.1186/2051-1426-3-S2-P372 |
| work_keys_str_mv | AT skarzynskimartin monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants AT lindorfermargeret monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants AT buteravicent monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants AT vireberengere monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants AT farooquimohammed monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants AT raderchristoph monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants AT taylorronald monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants AT wiestneradrian monoclonalantibodiestargetingcellsurfacedepositedcomplementfragmentc3dpotentiatecancerimmunotherapyandeliminateantigenlossvariants |